Loading...

    Explore
    • Policy Monitoring
    • Live Policy Feed
    • Billing Codes
    • Healthcare Providers
    • Health Insurance Payers
    • States
    • Service Lines
    • Taxonomy Codes
    Lookup tools
    • Billing Code Lookup
    • CPT Modifier Lookup
    • Provider Taxonomy Code Lookup
    • Healthcare Provider & Facility Lookup
    • Health Insurance Payer Lookup
    • Payer Contact Directory

    Policy & Benchmark Tools

    • Prior Authorization Lookup
    • Coverage Criteria Lookup
    • Timely Filing Lookup
    • Billing Code Reimbursement Rates
    • Payer Comparison Dashboard
    • Facility Comparison Dashboard
    • All tools

    Company

    • About OpenPayer
    • Data Sources
    • Request a Policy / Feedback
    • Trek Health
    OpenPayerby Trek Health
    LinkedInYouTube

    © 2026 Trek Health. All rights reserved.

    OpenPayer is built and maintained by Trek Health.

    v1.0.31
    OpenPayerPolicy UpdatesReimbursement/Payment PolicyBlue Cross Blue Shield ND Prior Auth Restricted Dr…
    Ask Trek AI about this page
    CurrentBlue Cross Blue Shield - North DakotaPolicy N/A

    Medicaid Expansion Restricted Use Drug Precertification List

    Customize your policy alerts

    Sign up for all Blue Cross Blue Shield - North Dakota policy alerts

    Know when Blue Cross Blue Shield - North Dakota releases new policies or updates existing guidance.

    Monitor payer policy activity

    Receive email alerts as soon as relevant payer policies are published or updated.

    Defines drugs subject to precertification (prior approval) and limited dispensing amounts for Blue Cross Blue Shield of North Dakota Medicaid Expansion; applies to providers and pharmacy/medical benefit processing for impacted members.

    OpenPayer is powered by Trek Health's payer performance platform. Trek continuously ingests, validates, and normalizes Transparency in Coverage data alongside payer policies and other commercial payer data to create a structured payer intelligence foundation. OpenPayer uses this foundation to deliver personalized search results, dynamically generated policy pages, and tailored policy monitoring based on each user's payers, specialties, billing codes, and areas of interest. The same intelligence powers broader payer performance workflows, including reimbursement benchmarking, contract evaluation, payer negotiations, and financial decision-making.

    Policy Summary
    PayerBlue Cross Blue Shield - North Dakota
    PolicyMedicaid Expansion Restricted Use Drug Precertification List
    Policy CodePolicy N/A
    Change TypeNo material changes
    Effective DateN/A
    Last ReviewJun 1, 2026
    Next Review DateN/A
    Key ActionObtain precertification (prior approval) for any restricted use drug, including brand and generic equivalents.
    SourceLink
    POLICY UPDATE CHANGES

    No material clinical or coverage changes in this revision.

    ~250+listed restricted use drugs (brand and codes) in this partial document
    Bothbrand and generic equivalents require precertification
    Pharmacy POScodes processed through pharmacy point-of-sale systems
    1-833-777-5779primary contact phone for language assistance
    Multiple CGM codescontinuous glucose monitoring device and supply codes referenced

    Coverage and Prior Authorization Criteria

    Precertification / Indication Requirements

    Drugs on this Restricted Use List require precertification; both brand name products and their generic equivalents require prior approval.

    Precertification (Prior Approval) is required for drugs listed on the Medicaid Expansion Restricted Use List.

    ALL of the following

    • Both brand name drugs and generic equivalents require Precertification (Prior Approval).
    • For medications not on this list, FDA or compendia-supported indications are required.
    • Medical drugs covered under the medical benefit require prior authorization per BCBSND medical prior authorization resources (see Policies & Prior Authorization).

    Pharmacy benefit processing and supply allowances

    Coverage routing and supply allowances for listed codes:

    Self-administered medications that do not require professional administration are typically payable under the pharmacy benefit and are processed through pharmacy point-of-sale systems per the Department of Human Services Preferred Drug list.
    Adjunctive and non-adjunctive continuous glucose monitor (CGM) supplies and components have specified supply allowances: A4239 = adjunctive CGM 1 month = 1 unit; A9276 = non-adjunctive CGM 1 month = 1 unit; A9277 = sensor, one unit = 1 day supply; A9278 = transmitter; E2102/E2103 = receiver/adjunctive or non-adjunctive receiver as described.
    An extensive list of J-, Q-, S-, A-, and other HCPCS codes are included for processing via pharmacy POS; individual items may still require medical benefit prior authorization where applicable.

    Codes and Billing References

    Representative HCPCS/J-codes from listHCPCSCovered
    J3262TOCILIZUMAB (example from list)
    J2507PEGLOTICASE (example from list)
    Selected injectable/biologic J-/Q-codes and descriptionsHCPCS
    J1558Immune globulin (human) subcutaneous (Xembify)
    J0218Olipudase alfa (Xenpozyme)
    J0588Incobotulinum toxin A (Xeomin)
    J0775Collagenase (Xiaflex)
    J2357Omalizumab (Xolair) healthcare administered
    J9228Ipilimumab (Yervoy)
    Q2041Axicabtagene ciloleucel (Yescarta)
    J9359Tesirine-LPYL (Zynlonta)
    J3393Betibeglogene autotemcel (Zynteglo)
    J9345Retifanlimab-DLWR (Zynyz)

    Provider Requirements and Member Assistance

    Prior Authorization

    Precertification / Prior Authorization Requirement

    Precertification (Prior Authorization) is required for restricted use drugs. Both brand name drugs and their generic equivalents require precertification prior to coverage under the medical benefit.

    • All restricted use drugs (brand and generic) require precertification / prior authorization.
    • See BCBSND Policies & Prior Authorization for medical drug prior authorization details.
    • Preferred Drug List (PDL) determines pharmacy vs medical benefit processing and additional prior authorization requirements: http://www.hidesigns.com/ndmedicaid/pdl/.
    Billing Rule

    Processing via Pharmacy Point-of-Sale; Benefit Determination

    Certain drugs and diabetic supplies are processed through pharmacy point-of-sale (POS) systems per the Department of Human Services Preferred Drug List. Codes listed in this policy that represent self-administered medications, supplies or CGM supplies are billed and adjudicated via the pharmacy benefit at POS rather than the medical benefit.

    Definitions and Terminology

    Restricted Use Drug — Definition
    TermRestricted Use Drug
    DefinitionA Prescription Medication or Drug that may require Precertification (Prior Approval) and/or be subject to a limited dispensing amount.
    ActionBoth brand name drugs and generic equivalents require precertification (Prior Approval).
    Medical Drug — Definition
    TermMedical Drug
    DefinitionA drug that is covered under the medical benefit and requires Precertification (Prior Approval).
    Reference
    Policy Summary
    PayerBlue Cross Blue Shield - North Dakota
    PolicyMedicaid Expansion Restricted Use Drug Precertification List
    Policy CodePolicy N/A
    Change TypeNo material changes
    Effective DateN/A
    Last ReviewJun 1, 2026
    Next Review DateN/A
    Key ActionObtain precertification (prior approval) for any restricted use drug, including brand and generic equivalents.
    SourceLink
    On This Page
    Coverage and Prior Authorization CriteriaCodes and Billing ReferencesProvider Requirements and Member AssistanceDefinitions and Terminology
    • Pharmacy POS processing applies per the DHS Preferred Drug List; consult the most recent PDL to determine benefit routing (pharmacy vs medical) and any precertification requirements.
    • Examples of codes processed via pharmacy POS include (non-exhaustive): A4238 (adjunctive CGM supply allowance, 1 month = 1 unit), A4239 (non-adjunctive non-implanted CGM supply allowance), A9276 (CGM supplies).
    • Self-administered medications that do not require professional administration are typically payable on the pharmacy benefit; see Medical Policy: Medications and Diabetic Supplies Payable on the Pharmacy Benefit for details.
    Note

    Drug Indications and Coverage

    If a medication is not on the restricted use list, FDA or compendia-supported indications are required for coverage determination. Consult the Drug Indications (Medicaid Expansion) guidance and the Precertification Drug List for specific drugs and codes.

    • Drug indications must be supported by FDA labeling or compendia when medication is not listed on the restricted use list.
    • Refer to the Precertification Drug List for specific drug-level prior authorization codes and requirements.
    Note

    Deutsch (German)

    Wenn Sie Deutsch sprechen, stehen Ihnen kostenlos sprachliche Hilfsdienstleistungen zur Verfügung. Rufnummer: (1-833-777-5779) (TTY: 1-800-366-6888 oder 711).

    Note

    中文 (Chinese)

    注意:如果您使用繁體中文,您可以免費獲得語言援助服務。請致電 (1-833-777-5779) (TTY:1-800-366-6888 或 711)。

    Note

    Oroomiffa (Oromo)

    XIYYEEFFANNAA: Afaan dubbattu Oroomiffa, tajaajila gargaarsa afaanii, kanfaltiidhaan ala, ni argama. Bilbilaa (1-833-777-5779) (TTY: 1-800-366-6888 ykn 711).

    Note

    Tiếng Việt (Vietnamese)

    CHÚ Ý: Nếu bạn nói Tiếng Việt, có các dịch vụ hỗ trợ ngôn ngữ miễn phí dành cho bạn. Gọi số (1-833-777-5779) (TTY: 1-800-366-6888 hoặc 711).

    Note

    Ikirundi (Bantu - Kirundi)

    ICITONDERWA: Nimba uvuga Ikirundi, uzohabwa serivisi zo gufasha mu ndimi, ku buntu. Woterefona (1-833-777-5779) (TTY: 1-800-366-6888 canke 711).

    Note

    العربية (Arabic)

    ملحوظة: إذا كنت تتحدث اذكر اللغة، فإن خدمات المساعدة اللغوية تتوافر لك بالمجان. اتصل برقم (1-833-777-5779) (رقم هاتف الصم والبكم: 1-800-366-6888 أو 711).

    Note

    Kiswahili (Swahili)

    KUMBUKA: Ikiwa unazungumza Kiswahili, unaweza kupata, huduma za lugha, bila malipo. Piga simu (1-833-777-5779) (TTY: 1-800-366-6888 au 711).

    Note

    Русский (Russian)

    ВНИМАНИЕ: Если вы говорите на русском языке, то вам доступны бесплатные услуги перевода. Звоните (1-833-777-5779) (телетайп: 1-800-366-6888 или 711).

    Note

    日本語 (Japanese)

    注意事項:日本語を話される場合、無料の言語支援をご利用いただけます。 (1-833-777-5779) (TTY: 1-800-366-6888 または 711)まで、お電話にてご連絡ください。

    Note

    नेपाली (Nepali)

    ध्यान दिनुहोस् : तपार्इंले नेपाली बोल्नुहुन्छ भने तपार्इंको भाषा सहायता सेवाहरू नि:शुल्क रूपमा उपलब्ध छ । फोन गर्नुहोस् (1-833-777-5779) (TTY : 1-800-366-6888 वा 711)।

    Note

    Français (French)

    ATTENTION : Si vous parlez français, des services d'aide linguistique vous sont proposés gratuitement. Appelez le (1-833-777-5779) (ATS : 1-800-366-6888 ou 711).

    Note

    한국어 (Korean)

    주의 : 한국어를 사용하시는 경우, 언어 지원 서비스를 무료로 이용하실 수 있습니다. (1-833-777-5779) (TTY: 1-800-366-6888 또는 711) 번으로 전화해 주십시오.

    Note

    Tagalog (Tagalog - Filipino)

    PAUNAWA: Kung nagsasalita ka ng Tagalog, maaari kang gumamit ng mga serbisyo ng tulong sa wika nang walang bayad. Tumawag sa (1-833-777-5779) (TTY: 1-800-366-6888 o 711).

    Note

    Norsk (Norwegian)

    MERK: Hvis du snakker norsk, er gratis språkassistansetjenester tilgjengelige for deg. Ring (1-833-777-5779) (TTY: 1-800-366-6888 eller 711).

    Note

    Diné Bizaad (Navajo)

    Díí baa akó nínízin: Díí saad bee yán íłti'go Diné Bizaad, saad bee áká'ání da'á wo'dę́ę́, t'áá jiik'eh, éí ná hólǫ́, kojį'hódíílnih (1-833-777-5779) (TTY: 1-800-366-6888 éí doodagó 711).

    Prior authorizations information for medical drugs available on BCBSND Policies & Prior Authorization.
    Preferred Drug List (PDL) — Definition
    TermPreferred Drug List (PDL)
    DefinitionA list of medications that are preferred and processed by pharmacy point-of-sale systems; consult the most recent PDL to determine additional Precertification or Prior Approval requirements and benefit processing.
    Linkhttp://www.hidesigns.com/ndmedicaid/pdl/
    Self-administered medications — Definition
    TermSelf-administered medications
    DefinitionMedications administered by an individual that do not require professional administration by a healthcare provider and are not typically covered under the medical benefit.
    ReferenceSee Medical Policy: Medications and Diabetic Supplies Payable on the Pharmacy Benefit for pharmacy coverage guidance.
    Continuous glucose monitoring supplies — Definition & allowances
    TermContinuous glucose monitoring supplies
    DefinitionDevice components and supplies for continuous glucose monitoring (sensor, transmitter, receiver) with specified supply allowances (e.g., A4238, A4239, A9276, A9277, A9278, E2102, E2103); allowances differ for adjunctive and non-adjunctive devices (1 month supply = 1 unit of service for certain codes).
    Examples of codesA4238, A4239, A9276, A9277, A9278, E2102, E2103, S1030-S1037 (selected CGM/device codes)
    Language assistance services — Definition
    TermLanguage assistance services
    DefinitionFree language translation and interpretation services provided to members in multiple languages at no cost.
    ContactCall 1-833-777-5779 (TTY: 1-800-366-6888 or 711) for assistance in listed languages (examples include German, Chinese, Oromo).